7.55
price down icon2.08%   -0.16
after-market Dopo l'orario di chiusura: 7.69 0.14 +1.85%
loading
Precedente Chiudi:
$7.71
Aprire:
$7.57
Volume 24 ore:
5,265
Relative Volume:
0.13
Capitalizzazione di mercato:
$30.52M
Reddito:
$147.75M
Utile/perdita netta:
$-284.23M
Rapporto P/E:
-2.5768
EPS:
-2.93
Flusso di cassa netto:
$-317.54M
1 W Prestazione:
+0.40%
1M Prestazione:
+39.30%
6M Prestazione:
-40.34%
1 anno Prestazione:
-75.65%
Intervallo 1D:
Value
$7.55
$7.69
Intervallo di 1 settimana:
Value
$7.3113
$8.3561
Portata 52W:
Value
$4.50
$34.25

Fibrogen Inc Stock (FGEN) Company Profile

Name
Nome
Fibrogen Inc
Name
Telefono
415-978-1200
Name
Indirizzo
350 BAY STREET, SAN FRANCISCO, CA
Name
Dipendente
225
Name
Cinguettio
@FibroGenInc
Name
Prossima data di guadagno
2025-03-17
Name
Ultimi documenti SEC
Name
FGEN's Discussions on Twitter

Confronta FGEN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
FGEN
Fibrogen Inc
7.55 31.16M 147.75M -284.23M -317.54M -2.93
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Fibrogen Inc Stock (FGEN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-08-08 Downgrade BofA Securities Neutral → Underperform
2023-06-26 Downgrade BofA Securities Buy → Neutral
2023-06-26 Downgrade Raymond James Outperform → Mkt Perform
2023-06-26 Downgrade Stifel Buy → Hold
2023-06-26 Downgrade William Blair Outperform → Mkt Perform
2023-06-02 Aggiornamento Stifel Hold → Buy
2023-01-31 Aggiornamento William Blair Mkt Perform → Outperform
2023-01-26 Aggiornamento Raymond James Mkt Perform → Outperform
2023-01-05 Aggiornamento BofA Securities Neutral → Buy
2021-09-22 Downgrade Goldman Neutral → Sell
2021-08-20 Aggiornamento Raymond James Underperform → Mkt Perform
2021-07-16 Downgrade BofA Securities Buy → Neutral
2021-07-16 Downgrade Stifel Buy → Hold
2021-04-07 Downgrade H.C. Wainwright Buy → Neutral
2021-04-07 Downgrade Mizuho Buy → Neutral
2021-03-31 Aggiornamento BofA Securities Neutral → Buy
2021-03-02 Downgrade Jefferies Buy → Hold
2021-02-01 Iniziato H.C. Wainwright Buy
2020-10-26 Iniziato Raymond James Underperform
2020-07-10 Ripresa Stifel Buy
2020-05-01 Iniziato Cowen Market Perform
2020-04-27 Iniziato BofA/Merrill Neutral
2019-05-29 Ripresa Goldman Neutral
2019-05-10 Downgrade William Blair Outperform → Mkt Perform
2019-04-12 Iniziato Piper Jaffray Neutral
2019-02-11 Ripresa Stifel Buy
2018-12-19 Aggiornamento Citigroup Neutral → Buy
2017-08-08 Reiterato Leerink Partners Outperform
2017-08-08 Reiterato Stifel Buy
2017-07-21 Downgrade Goldman Buy → Neutral
2017-07-11 Iniziato Jefferies Buy
2016-02-11 Aggiornamento Credit Suisse Neutral → Outperform
2016-01-21 Iniziato Credit Suisse Neutral
2015-12-04 Iniziato Citigroup Buy
2015-09-23 Iniziato Lake Street Hold
2015-07-29 Iniziato Citigroup Buy
2015-07-20 Aggiornamento Goldman Neutral → Buy
2014-12-09 Iniziato Stifel Buy
Mostra tutto

Fibrogen Inc Borsa (FGEN) Ultime notizie

pulisher
Jul 23, 2025

What analysts say about FibroGen Inc. stockTremendous return on equity - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is FibroGen Inc. a good long term investmentFree Market Volatility Navigation Tips - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

FibroGen Inc. Stock Analysis and ForecastFastest return on investment - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What drives FibroGen Inc. stock priceMarket-leading capital gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

40-Year Biotech Veteran Jim Schoeneck Joins Connect Biopharma Board as Asthma Drug Enters Critical Phase - Stock Titan

Jul 22, 2025
pulisher
Jul 17, 2025

Why FibroGen Inc. stock attracts strong analyst attentionSafe and Smart Investment Picks - beatles.ru

Jul 17, 2025
pulisher
Jul 15, 2025

What makes FibroGen Inc. stock price move sharplyFree Investment Community - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How FibroGen Inc. stock performs during market volatilityParabolic Move Ideas - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

FibroGen amends financing agreement to reduce minimum cash balance requirement By Investing.com - Investing.com South Africa

Jul 14, 2025
pulisher
Jul 14, 2025

FibroGen amends financing agreement to reduce minimum cash balance requirement - Investing.com Australia

Jul 14, 2025
pulisher
Jun 16, 2025

FibroGen (FGEN) Trading Halted Pending News Release | FGEN Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 13, 2025

FibroGen Enters New Agreement with HiFiBiO - TipRanks

Jun 13, 2025
pulisher
Jun 13, 2025

Fibrogen IncOn June 12 Enters Termination, Asset Transfer And License Agreement With Hifibio - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

FibroGen (FGEN) Announces 1-for-25 Reverse Stock Split | FGEN St - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

FibroGen to implement 1-for-25 reverse stock split; shares down 15% - MSN

Jun 13, 2025
pulisher
Jun 13, 2025

Adobe, FibroGen And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga

Jun 13, 2025
pulisher
Jun 13, 2025

FibroGen Announces 1-for-25 Reverse Stock Split - The Manila Times

Jun 13, 2025
pulisher
Jun 12, 2025

Adobe, RH And 3 Stocks To Watch Heading Into FridayAdobe (NASDAQ:ADBE), FibroGen (NASDAQ:FGEN) - Benzinga

Jun 12, 2025
pulisher
Jun 12, 2025

FibroGen Announces 1-for-25 Reverse Stock Split | FGEN Stock New - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

FibroGen Announces Reverse Stock Split Effective June 16 - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

FibroGen to Implement 1-for-25 Reverse Stock Split - marketscreener.com

Jun 12, 2025
pulisher
Jun 12, 2025

FibroGen To Implement 1-for-25 Reverse Stock Split - Nasdaq

Jun 12, 2025
pulisher
Jun 12, 2025

FibroGen, Inc. Announces 1-for-25 Reverse Stock Split Effective June 16, 2025 - Nasdaq

Jun 12, 2025
pulisher
Jun 12, 2025

Fibrogen Announces 1-For-25 Reverse Stock Split - marketscreener.com

Jun 12, 2025
pulisher
Jun 12, 2025

FibroGen's Massive 1-for-25 Reverse Split Cuts 101M Shares to 4MWhat Investors Must Know - Stock Titan

Jun 12, 2025
pulisher
Jun 10, 2025

Millennium Management LLC Lowers Stock Position in FibroGen, Inc. (NASDAQ:FGEN) - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

FibroGen expands board with biotech veteran Kauffman By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

FibroGen expands board with biotech veteran Kauffman - Investing.com Australia

Jun 09, 2025
pulisher
Jun 09, 2025

FibroGen Amends Financing Agreement for Flexibility - TipRanks

Jun 09, 2025
pulisher
Jun 09, 2025

FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Directors | FGEN Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Fibrogen Appoints Michael Kauffman To Its Board Of Directors - marketscreener.com

Jun 09, 2025
pulisher
Jun 09, 2025

FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Directors - GlobeNewswire

Jun 09, 2025
pulisher
Jun 09, 2025

FibroGen Strengthens Board with Velcade Developer: Key Move for Pipeline Advancement - Stock Titan

Jun 09, 2025
pulisher
Jun 09, 2025

Squarepoint Ops LLC Takes Position in FibroGen, Inc. (NASDAQ:FGEN) - Defense World

Jun 09, 2025

Fibrogen Inc Azioni (FGEN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Capitalizzazione:     |  Volume (24 ore):